Terms: = Thyroid cancer AND AFP, AFPD, FETA, HPAFP AND Prognosis
12 results:
1. Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature.
Li Q; Feng T; Zhu T; Zhang W; Qian Y; Zhang H; Zheng X; Li D; Yun X; Zhao J; Li Y; Yu H; Gao M; Qian B
J Transl Med; 2023 Mar; 21(1):206. PubMed ID: 36941725
[TBL] [Abstract] [Full Text] [Related]
2. The Impact of a History of Different Other cancers on the Long-Term Outcomes of Patients with Intrahepatic Cholangiocarcinoma: A Population-Based Analysis.
Chai J; Kong J; Zhu K
Biomed Res Int; 2022; 2022():3970884. PubMed ID: 35257009
[TBL] [Abstract] [Full Text] [Related]
3. TUG1 Is a Regulator of afp and Serves as Prognostic Marker in Non-Hepatitis B Non-Hepatitis C Hepatocellular Carcinoma.
Lin YH; Wu MH; Huang YH; Yeh CT; Lin KH
Cells; 2020 Jan; 9(2):. PubMed ID: 31973032
[TBL] [Abstract] [Full Text] [Related]
4. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract] [Full Text] [Related]
5. High expression of hexokinase domain containing 1 is associated with poor prognosis and aggressive phenotype in hepatocarcinoma.
Zhang Z; Huang S; Wang H; Wu J; Chen D; Peng B; Zhou Q
Biochem Biophys Res Commun; 2016 Jun; 474(4):673-679. PubMed ID: 27155152
[TBL] [Abstract] [Full Text] [Related]
6. Multiple Primary Malignancies in Patients With Hepatocellular Carcinoma: A Largest Series With 26-Year Follow-Up.
Xu W; Liao W; Ge P; Ren J; Xu H; Yang H; Sang X; Lu X; Mao Y
Medicine (Baltimore); 2016 Apr; 95(17):e3491. PubMed ID: 27124050
[TBL] [Abstract] [Full Text] [Related]
7. Mediastinal teratomas in children. Case reports and review of the literature.
Paradies G; Zullino F; Orofino A; Leggio S
Ann Ital Chir; 2013; 84(4):395-403. PubMed ID: 23685310
[TBL] [Abstract] [Full Text] [Related]
8. Pituitary choriocarcinoma in an adolescent male: tumor-derived CG and GH delay diagnosis.
Wildi-Runge S; Crevier L; Carret AS; Robitaille Y; Deal C
Growth Horm IGF Res; 2011 Jun; 21(3):181-4. PubMed ID: 21658594
[TBL] [Abstract] [Full Text] [Related]
9. Phase I clinical trial of targeted therapy using 131I-Hepama-1 mAb in patients with hepatocellular carcinoma.
Chen S; Li B; Xie H; Xu L; Niu G; Fan K; Fan Q
Cancer Biother Radiopharm; 2004 Oct; 19(5):589-600. PubMed ID: 15650451
[TBL] [Abstract] [Full Text] [Related]
10. Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.
Ishikawa T; Kashiwagi H; Iwakami Y; Hirai M; Kawamura T; Aiyoshi Y; Yashiro T; Ami Y; Uchida K; Miwa M
Jpn J Clin Oncol; 1998 Dec; 28(12):723-8. PubMed ID: 9879288
[TBL] [Abstract] [Full Text] [Related]
11. Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies.
Lau WY; Leung WT; Ho S; Lam SK; Li CY; Johnson PJ; Williams R; Li AK
Cancer; 1995 Jun; 75(11):2669-76. PubMed ID: 7743468
[TBL] [Abstract] [Full Text] [Related]
12. Metastasis of unknown origin.
Perchalski JE; Hall KL; Dewar MA
Prim Care; 1992 Dec; 19(4):747-57. PubMed ID: 1465485
[TBL] [Abstract] [Full Text] [Related]
